Lycopus lucidus Turcz Exerts Neuroprotective Effects Against H₂O₂-Induced Neuroinflammation by Inhibiting NLRP3 Inflammasome Activation in Cortical Neurons

References

• Kyritsis N, Kizil C, Brand M. Neuroinflammation and central nervous system regeneration in vertebrates. Trends Cell Biol. 2014;24(2):128–135. doi:10.1016/j.tcb.2013.08.004
   PubMed Web of Science ®Google Scholar
• Erickson MA, Dohi K, Banks WA. Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation. 2012;19(2):121–130. doi:10.1159/000330247
   PubMed Web of Science ®Google Scholar
• Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204–7218. doi:10.18632/oncotarget.23208
   PubMedGoogle Scholar
• Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771–776. doi:10.1016/j.cell.2010.03.006
   PubMed Web of Science ®Google Scholar
• Saresella M, La Rosa F, Piancone F, et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease. Mol Neurodegener. 2016;11(1):23. doi:10.1186/s13024-016-0088-1
   PubMedGoogle Scholar
• Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Immunity. 2019;50(4):778–795. doi:10.1016/j.immuni.2019.03.012
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: an Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420. doi:10.1038/nri.2016.58
   PubMed Web of Science ®Google Scholar
• Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–735. doi:10.1146/annurev-immunol-031210-101405
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128. doi:10.1038/s41419-019-1413-8
   PubMed Web of Science ®Google Scholar
• Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK. Targeting the microglial NLRP3 inflammasome and its role in Parkinson’s disease. Mov Disord. 2020;35(1):20–33. doi:10.1002/mds.27874
   PubMed Web of Science ®Google Scholar
• Hong P, Gu RN, Li FX, et al. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation. 2019;16(1):121. doi:10.1186/s12974-019-1498-0
   PubMed Web of Science ®Google Scholar
• Lee E, Hwang I, Park S, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ. 2019;26(2):213–228. doi:10.1038/s41418-018-0124-5
   PubMed Web of Science ®Google Scholar
• Li SJ, Zhang YF, Ma SH, et al. The role of NLRP3 inflammasome in stroke and central poststroke pain. Medicine. 2018;97(33):e11861. doi:10.1097/MD.0000000000011861
   PubMed Web of Science ®Google Scholar
• Tan MS, Yu JT, Jiang T, Zhu XC, Tan L. The NLRP3 inflammasome in Alzheimer’s disease. Mol Neurobiol. 2013;48(3):875–882. doi:10.1007/s12035-013-8475-x
   PubMed Web of Science ®Google Scholar
• Kuwar R, Rolfe A, Di L, et al. A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflammation. 2019;16(1):81. doi:10.1186/s12974-019-1471-y
   PubMedGoogle Scholar
• Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8(1):5971. doi:10.1038/s41598-018-24350-x
   PubMedGoogle Scholar
• Ismael S, Ahmed HA, Adris T, Parveen K, Thakor P, Ishrat T. The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury. Neural Regen Res. 2021;16(1):49–57. doi:10.4103/1673-5374.286951
   PubMed Web of Science ®Google Scholar
• Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: an Overview. Medicines. 2018;5(3).
   Google Scholar
• Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270–278. doi:10.4161/oxim.2.5.9498
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhang L, Sun S, Yi Z, Jiang X, Jia D. Neuroprotective effects of syringic acid against OGD/R-induced injury in cultured hippocampal neuronal cells. Int J Mol Med. 2016;38(2):567–573. doi:10.3892/ijmm.2016.2623
   PubMed Web of Science ®Google Scholar
• Ogut E, Sekerci R, Akcay G, et al. Protective effects of syringic acid on neurobehavioral deficits and hippocampal tissue damages induced by sub-chronic deltamethrin exposure. Neurotoxicol Teratol. 2019;76:106839. doi:10.1016/j.ntt.2019.106839
   PubMed Web of Science ®Google Scholar
• Rashedinia M, Alimohammadi M, Shalfroushan N, et al. Neuroprotective Effect of Syringic Acid by Modulation of Oxidative Stress and Mitochondrial Mass in Diabetic Rats. Biomed Res Int. 2020;2020:8297984. doi:10.1155/2020/8297984
   PubMed Web of Science ®Google Scholar
• Khojasteh A, Mirjalili MH, Alcalde MA, Cusido RM, Eibl R, Palazon J. Powerful Plant Antioxidants: a New Biosustainable Approach to the Production of Rosmarinic Acid. Antioxidants. 2020;9(12). doi:10.3390/antiox9121273
   Web of Science ®Google Scholar
• Jeong DW, Kim EY, Kim JH, et al. Lycopus lucidus Turcz Inhibits the Osteoclastogenesis in RAW 264.7 Cells and Bone Loss in Ovariectomized Rat Model. Evid Based Complement Alternat Med. 2019;2019:3231784. doi:10.1155/2019/3231784
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kang DG, Kim JS, Lee HS. Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells. Vascul Pharmacol. 2008;48(1):38–46. doi:10.1016/j.vph.2007.11.004
   PubMed Web of Science ®Google Scholar
• Yu JQ, Lei JC, Zhang XQ, et al. Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. Food Chem. 2011;126(4):1593–1598. doi:10.1016/j.foodchem.2010.12.027
   PubMed Web of Science ®Google Scholar
• Pacifici M, Peruzzi F, Isolation and culture of rat embryonic neural cells: a quick protocol. J Vis Exp. 2012;63:e3965. doi:10.3791/3965
   PubMed Web of Science ®Google Scholar
• Shi H, Liu KJ. Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neurosci Lett. 2006;410(1):57–61. doi:10.1016/j.neulet.2006.09.066
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park B, Huh HW, et al. Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment. Pharmaceutics. 2020;12(2):165. doi:10.3390/pharmaceutics12020165
   PubMed Web of Science ®Google Scholar
• Kim JW, Mahapatra C, Hong JY, et al. Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles. Adv Sci. 2017;4(10):1700034. doi:10.1002/advs.201700034
   Web of Science ®Google Scholar
• Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254–1266. doi:10.7150/ijbs.4679
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Nunez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41(12):1012–1021. doi:10.1016/j.tibs.2016.09.002
   PubMed Web of Science ®Google Scholar
• Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10(3):241–247. doi:10.1038/ni.1703
   PubMed Web of Science ®Google Scholar
• Weissmiller AM, Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders. Transl Neurodegener. 2012;1(1):14. doi:10.1186/2047-9158-1-14
   PubMedGoogle Scholar
• McAllister AK. Dynamic aspects of CNS synapse formation. Annu Rev Neurosci. 2007;30(1):425–450. doi:10.1146/annurev.neuro.29.051605.112830
   PubMedGoogle Scholar
• Keefe KM, Sheikh IS, Smith GM. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int J Mol Sci. 2017;18(3):548. doi:10.3390/ijms18030548
   PubMed Web of Science ®Google Scholar
• Fusco R, Siracusa R, Genovese T, Cuzzocrea S, Di Paola R. Focus on the Role of NLRP3 Inflammasome in Diseases. Int J Mol Sci. 2020;21(12):4223. doi:10.3390/ijms21124223
   PubMed Web of Science ®Google Scholar
• Pellegrini C, Fornai M, Antonioli L, Blandizzi C, Calderone V. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases. Int J Mol Sci. 2019;20(12):2876. doi:10.3390/ijms20122876
   PubMed Web of Science ®Google Scholar